Previous studies had reported that CTLA4-CD28 chimera gene-modified T cell, which the intracellular signaling domain of CTLA4 was replaced with the CD28 signaling domain, showed significantly enhanced anti-tumor effect in murine tumor models (24, 25). Here, CTLA4 is linked to neoplasm.